Search
for

    Sort by

    Research 61–90 of 340

    1. Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS International Journal of Molecular Sciences · 2020 · 26 citations
    2. Fibroblasts: Immunomodulatory factors in refractory diabetic wound healing Frontiers in Immunology · 2022 · 20 citations
    3. Quercetin and polycystic ovary syndrome Frontiers in Pharmacology · 2022 · 6 citations
    4. RSPO1, a potent inducer of pancreatic β cell neogenesis Cell Reports Medicine · 2025 · 1 citations
    5. The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review Metabolites · 2023 · 1 citations
    6. Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization Biomolecules · 2026
    7. Spatiotemporal regulation of acute wound healing by the NLRP3 inflammasome: dual roles in macrophage-fibroblast chemotaxis and phenotype during wound repair Burns & Trauma · 2026
    8. Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion npj Breast Cancer · 2025
    9. Exosomal microRNA-Based therapies for skin diseases Regenerative therapy · 2023
    10. Mechanisms of Impaired Skeletal Muscle Regeneration and Therapeutic Approaches in Aging and Chronic Disease Pharmaceuticals · 2026
    11. Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response International Journal of Endocrinology · 2026
    12. Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025 Frontiers in Endocrinology · 2025
    13. Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review Pharmaceuticals · 2023
    14. European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity European Journal of Endocrinology · 2020 · 175 citations
    15. Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease Journal of Neuroimmune Pharmacology · 2023 · 9 citations
    16. Intrinsic factors in the pathogenesis of hidradenitis suppurativa: Genetics, hormones, and the microbiome Journal of the American Academy of Dermatology · 2024 · 7 citations
    17. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications Medical Review · 2024 · 6 citations
    18. Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome Frontiers in Pharmacology · 2025 · 1 citations
    19. The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review International journal of molecular sciences · 2024 · 1 citations
    20. Ganoderma lucidum extract attenuates corticotropin-releasing hormone induced cellular senescence in human hair follicle cells iScience · 2024
    21. Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease Journal of Clinical Medicine · 2026
    22. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial Cureus · 2021 · 41 citations
    23. Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical) Cureus · 2021 · 41 citations
    24. Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches PROTEOMICS · 2025
    25. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses PLoS medicine · 2024
    26. Are Pediatric GLP ‐1 Receptor Agonist Cutaneous Adverse Events Being Overlooked? Emerging Age‐Specific Patterns and Their Implications for Dermatologists Pediatric Dermatology · 2026 · 1 citations
    27. Nonscarring Alopecia in Adults Treated With GLP ‐1s: A Propensity Score Matched TriNetX Cohort Study The Laryngoscope · 2026
    28. 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review Journal of Investigative Dermatology · 2026
    29. 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization Journal of the American Academy of Dermatology · 2026
    30. Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action Annals of Clinical Pathology · 2026